Here you find a selection of projects realized by Jürg Kurmann for which he was the responsible leader and in which he also has personally performed the major work part.
Structuring of important price optimizing financial definitions in connection with closing accounts items at the sale to the NYSE-listed Luxoft.
Systematic target research in German speaking Switzerland. Initiating and supporting the negotiations in a leading role, structuring the transactions and support of the transaction processes until completion of the acquisitions of 100% of the share capital of Tiro Personal AG and MBT AG, both Zürich.
Joint Venture between Tritec and the Swiss-German Energiedienst Holding AG for the markets of Switzerland and Germany.
Systematic target search in Europe for the English Halma plc. Identification and completion of a purchase of the Swiss Medicel AG, a leading global manufacturer of intraocular lenses.
Global «360 degree» search- and buy-project. Identification of the Irish Allergy Standards Ltd. with a in the USA leading label for allergy and asthma-friendly consumer goods and completion of a participation-based strategic partnership.
Design of the corporate governance; Development of the ownership strategy for the significant commercial blood fractionation business (ZLB) and coaching of the process for the decision to divest which was then carried out by an investment bank.
Review of all direct investments. Joining the Board of Kieser Training AG and sale of the minority participation to majority shareholders Mr. and Mrs. Kieser.
Active roles as Chairman of the Board of Directors, CEO and liquidator. Sale of the operative business to the German Biofibre GmbH. Auctioning of the production facilities.
Realization of succession solution concurrently with a growth financing for the company. Sale in two steps to the Italian Pierrel Pharmaceutici S.p.A.
Sale of the loss-making and substantially contingent liabilities burdened Bedag Gemeinden Informatik AG via several intermediate steps, including assuming the function as Executive Chairman of the Board of Directors.